NEW YORK (GenomeWeb News) – MDS shareholders have approved the sale of the firm's Analytical Technologies business to Danaher for $650 million in cash.

Shareholders representing more than 99 percent of MDS' common shares voted in favor of the sale at a meeting held Tuesday.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.